Fig. 6From: Potentiation of endocannabinoids and other lipid amides prevents hyperalgesia and inflammation in a pre-clinical model of migraineAEA (A, E, I), PEA (B, F, J), OEA (C, G, K) and 2-AG (D, H, L) levels (expressed in pmol/mg) in cervical spinal cord (CSC), medulla and trigeminal ganglia (TGs) of rats treated with NTG vehicle (CT), NTG, NTG + ARN14663 and NTG + ARN14280 (n. 6 per group). Data are expressed as mean ± SEM; Tukey’s multiple comparisons test; **p < 0.01 and ***p < 0.001 vs CT and NTG; °°p < 0.01 and °°°p < 0.001 vs NTG; ^p < 0.05 vs CT; §p < 0.05 vs NTG + ARN14633Back to article page